Spotlight influenza: Laboratory-confirmed seasonal influenza in people with acute respiratory illness: a literature review and meta-analysis, WHO European Region, 2004 to 2017
- PMID: 34596019
- PMCID: PMC8485580
- DOI: 10.2807/1560-7917.ES.2021.26.39.2000343
Spotlight influenza: Laboratory-confirmed seasonal influenza in people with acute respiratory illness: a literature review and meta-analysis, WHO European Region, 2004 to 2017
Abstract
BackgroundAcross the World Health Organization European Region, there are few estimates of the proportion of people seeking medical care for influenza-like illness or acute respiratory infections and who have laboratory-confirmed seasonal influenza infection.MethodsWe conducted a meta-analysis of data extracted from studies published between 2004 and 2017 and from sentinel data from the European surveillance system (TESSy) between 2004 and 2018. We pooled within-season estimates by influenza type/subtype, setting (outpatient (OP)/inpatient (IP)) and age group to estimate the proportion of people tested who have laboratory-confirmed and medically-attended seasonal influenza in Europe.ResultsIn the literature review, the pooled proportion for all influenza types was 33% (95% confidence interval (CI): 30-36), higher among OP 36% (95% CI: 33-40) than IP 24% (95% CI: 20-29). Pooled estimates for all influenza types by age group were: 0-17 years, 26% (22-31); 18-64 years, 41% (32-50); ≥ 65 years, 33% (27-40). From TESSy data, 33% (31-34) of OP and 24% (21-27) of IP were positive. The highest proportion of influenza A was in people aged 18-64 years (22%, 16-29). By subtype, A(H1N1)pdm09 was highest in 18-64 year-olds (16%, 11-21%) whereas A(H3N2) was highest in those ≥ 65 years (10%, 2-22). For influenza B, the highest proportion of infections was in those aged 18-64 years (15%, 9-24).ConclusionsLaboratory-confirmed influenza accounted for approximately one third of all acute respiratory infections for which medical care was sought during the influenza season.
Keywords: acute respiratory infection; influenza A virus; influenza B virus; influenza human; influenza-like illness; medically-attended.
Conflict of interest statement
Figures
Similar articles
-
Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.Euro Surveill. 2014 Feb 13;19(6):20701. doi: 10.2807/1560-7917.es2014.19.6.20701. Euro Surveill. 2014. PMID: 24556348
-
Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.Euro Surveill. 2016;21(7):pii=30139. doi: 10.2807/1560-7917.ES.2016.21.7.30139. Euro Surveill. 2016. PMID: 26924024
-
The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).Vaccine. 2015 Jun 4;33(24):2813-22. doi: 10.1016/j.vaccine.2015.04.012. Epub 2015 Apr 28. Vaccine. 2015. PMID: 25936723
-
Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza.Vaccine. 2017 Aug 3;35(34):4298-4306. doi: 10.1016/j.vaccine.2017.06.088. Epub 2017 Jul 11. Vaccine. 2017. PMID: 28709555
-
Variable seasonal influenza vaccine effectiveness across geographical regions, age groups and levels of vaccine antigenic similarity with circulating virus strains: A systematic review and meta-analysis of the evidence from test-negative design studies after the 2009/10 influenza pandemic.Vaccine. 2021 Feb 22;39(8):1225-1240. doi: 10.1016/j.vaccine.2021.01.032. Epub 2021 Jan 22. Vaccine. 2021. PMID: 33494964 Review.
Cited by
-
Low prevalence of influenza viruses and predominance of A(H3N2) virus with respect to SARS-CoV-2 during the 2021-2022 season in Bulgaria.J Med Virol. 2023 Feb;95(2):e28489. doi: 10.1002/jmv.28489. J Med Virol. 2023. PMID: 36832544 Free PMC article.
-
Burden of seasonal influenza in the Swiss adult population during the 2016/2017-2018/2019 influenza seasons.Influenza Other Respir Viruses. 2023 Nov;17(11):e13218. doi: 10.1111/irv.13218. Influenza Other Respir Viruses. 2023. PMID: 38019699 Free PMC article.
-
Evaluation of Hospitalized Patients with Community-Acquired Influenza-Like Illness During Two Influenza Seasons.Infect Dis Clin Microbiol. 2023 Dec 29;5(4):323-331. doi: 10.36519/idcm.2023.285. eCollection 2023 Dec. Infect Dis Clin Microbiol. 2023. PMID: 38633854 Free PMC article.
-
Simultaneous Detection of SARS-CoV-2 and Influenza Virus in Wastewater of Two Cities in Southeastern Germany, January to May 2022.Int J Environ Res Public Health. 2022 Oct 17;19(20):13374. doi: 10.3390/ijerph192013374. Int J Environ Res Public Health. 2022. PMID: 36293955 Free PMC article.
-
Contribution of Influenza Viruses, Other Respiratory Viruses and Viral Co-Infections to Influenza-like Illness in Older Adults.Viruses. 2022 Apr 12;14(4):797. doi: 10.3390/v14040797. Viruses. 2022. PMID: 35458527 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous